Welcome to our dedicated page for Surrozen, Inc./DE SEC filings (Ticker: SRZNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Surrozen, Inc./DE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Surrozen, Inc./DE's regulatory disclosures and financial reporting.
Surrozen, Inc. reported that Chief Executive Officer Craig C. Parker received new equity awards. On February 17, 2026, he was granted an employee stock option covering 242,200 shares of common stock at an exercise price of $0.0000 per share, held as direct ownership.
The option vests over four years in 48 equal monthly installments starting from February 1, 2026, conditioned on continued service. Parker was also granted 242,200 restricted stock units, each representing one share of common stock. These RSUs vest in four equal annual installments beginning on February 1, 2026, also subject to continued service.
Braidwell and affiliates disclosed a significant position in Surrozen, Inc. common stock. As of December 31, 2025, Braidwell LP, Braidwell Management LLC, Alexander T. Karnal, and Brian J. Kreiter may be deemed beneficial owners of 470,000 shares, representing about 5.5% of Surrozen’s outstanding common stock.
All 470,000 shares are directly owned by Braidwell Partners Master Fund LP, with each reporting person sharing voting and dispositive power and no sole authority. The stake is reported as being held in the ordinary course of business and not for the purpose of changing or influencing control of Surrozen.
Surrozen, Inc. received an updated ownership report showing that RA Capital Management, its affiliated fund, and principals Peter Kolchinsky and Rajeev Shah collectively report beneficial ownership of 871,731 shares of common stock, representing 9.2% of the class as of December 31, 2025.
The position includes Series A warrants for up to 322,580 shares, Series B warrants for up to 350,876 shares, and Series E warrants for up to 198,275 shares of common stock. The filing states the securities are not held for the purpose of changing or influencing control of Surrozen.
StemPoint Capital and related parties reported a significant ownership stake in Surrozen, Inc. The Schedule 13G/A shows StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross collectively beneficially owning 619,766 shares of Surrozen common stock, including 329,658 shares issuable upon exercise of warrants.
This represents 7.0% of Surrozen’s common stock, calculated using 8,571,421 shares outstanding as of November 5, 2025, plus specified Series A, B, and E warrants subject to a 9.9% beneficial ownership limitation. The filers state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Surrozen.
Stonepine Capital Management, Stonepine Capital, Stonepine GP and Jon M. Plexico filed an amended Schedule 13G reporting beneficial ownership of 316,289 shares of Surrozen, Inc. common stock, representing 3.6% of the class as of the reported date.
The stake consists of 113,631 shares of common stock plus 202,658 shares issuable upon exercise of Series A, Series B and Series E warrants, all subject to a 9.9% beneficial ownership limitation. The percentage is based on 8,571,421 shares outstanding as of November 5, 2025, and the filers certify the holdings are not for the purpose of changing or influencing control.
TCG Crossover investment entities increased their indirect stake in Surrozen, Inc. common stock through open-market purchases. On February 11, 2026, TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P. each bought 8,882 and 8,881 shares at $23.575 per share, respectively. On February 12, 2026, they bought additional blocks of 547 and 546 shares at $23.8625 per share. After these transactions, one fund reported beneficial ownership of 651,114 shares and the other 651,112 shares, all held indirectly through the TCG Crossover fund structure.
TCG Crossover investment entities reported open-market purchases of Surrozen, Inc. (SRZN) common stock. On January 30, 2026, TCG Crossover Fund II, L.P. bought 2,136 shares at $21.39 and TCG Crossover Fund III, L.P. bought 2,135 shares at $21.39, both indirectly held.
On February 2, 2026, Fund II purchased 366 shares at $21.38 and Fund III purchased 365 shares at $21.38. On February 3, 2026, Fund II bought 2,178 shares at $21.94, bringing its reported indirect holdings to 641,685 shares, while Fund III bought 2,177 shares at $21.94, bringing its reported indirect holdings to 641,682 shares.
TCG Crossover funds and Chen Yu report significant ownership in Surrozen, Inc. common stock. TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P., through their general partners, each report beneficial ownership of 637,005 shares, or 5.7% of Surrozen’s common stock.
Chen Yu, as sole managing member of both general partners, reports beneficial ownership of 1,274,010 shares, representing 11.4% of the outstanding common stock based on 11,191,978 shares outstanding as of January 27, 2026. The filing states the securities were not acquired or held for the purpose of changing or influencing control of Surrozen.
Surrozen, Inc. reported that board member Shao-Lee Lin, M.D., Ph.D. resigned from its Board of Directors, effective immediately on January 26, 2026. The company stated that Dr. Lin’s resignation was not due to any disagreement regarding Surrozen’s operations, policies, or practices. Surrozen expressed appreciation for her service and dedication to the company’s mission.
Surrozen, Inc. (SRZN) received an initial ownership report showing that investment entities affiliated with TCG Crossover hold significant stakes in its common stock. TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P., together with their general partners, each report indirect beneficial ownership of 637,005 shares of Surrozen common stock as of 01/26/2026. The funds hold the shares of record, while their general partners and Chen Yu, as sole managing member of each general partner, may be deemed to share voting, investment, and dispositive power over the reported securities.